About Contact Us Careers

Heparin Market Size and Forecast, by Product Type (Low Molecular Weight, Unfractionated); Route of Administration (Intravenous Infusion, Subcutaneous Injection); Application (Deep Vein Thrombosis, Heart Attacks, Stroke, Atrial Fibrillation); End-user (Hospitals, Clinics) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 3402
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Heparin Market Outlook:

Heparin Market size was over USD 8.99 billion in 2025 and is projected to reach USD 13.57 billion by 2035, growing at around 4.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of heparin is assessed at USD 9.33 billion.

Heparin Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The market growth is primarily driven by higher instances of cancer among the population. For instance, in 2040, the new cancer case count is anticipated to be nearly 28 million and the death toll is likely to reach around 16 million. Furthermore, rising prevalence of coronary artery disease and venous thromboembolism is fueling the market revenue.

Additionally, rising cases of accidents owing to vehicle crashes will propel the global heparin market growth. As per the data of the World Health Organization, road accident is the most common cause of death of children and adults aged 5 to 29 and about 1.3 million people every year die in road accident globally. Moreover, blood clotting during surgeries owing to several conditions will boost the market size.

Key Heparin Market Insights Summary:

  • Regional Highlights:

    • North America’s heparin market will dominate over 39.4% share by 2035, driven by a higher number of people developing chronic kidney diseases and increasing healthcare expenditure.
    • Asia Pacific market will expect significant growth during the forecast period 2026-2035, driven by the expansion in venous thromboembolism, cardiovascular diseases, and rising healthcare expenditure.

  • Segment Insights:

    • The heart attack segment in the heparin market is anticipated to hold the largest share by 2035, driven by the rising prevalence of heart-related disorders globally.
    • The subcutaneous injection segment in the heparin market is expected to maintain the largest share by 2035, driven by growing demand for home healthcare services and convenience in administration.

  • Key Growth Trends:

    • Growing Pressure of Chronic Diseases on the World 
    • Rising Cases of Thromboembolism

  • Major Challenges:

    • Growing Pressure of Chronic Diseases on the World 
    • Rising Cases of Thromboembolism

  • Key Players: Aspen Holdings, Opocrin S.p.A., LEO Pharma Inc., Baxter, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., B. Braun Medical Inc., Bioiberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada.

Global Heparin Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 8.99 billion
    • 2026 Market Size: USD 9.33 billion
    • Projected Market Size: USD 13.57 billion by 2035
    • Growth Forecasts: 4.2% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (39.4% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, Germany, China, France, United Kingdom
    • Emerging Countries: China, India, Japan, South Korea, Brazil

    • Last updated on : 8 September, 2025

Growth Drivers

  • Growing Pressure of Chronic Diseases on the World - Chronic diseases/Non-communicable diseases are currently the major cause of death among adults in almost all countries. This growing burden of chronic diseases is anticipated to boost the heparin market. As per the National Library of Medicine, every 3 in 5 deaths are attributed to a chronic disease such as cardiovascular disease, lung problem, diabetes, and others.

  • Rising Cases of Thromboembolism - In the United States, around 900,000 people are affected by pulmonary embolism or deep vein thrombosis. Moreover, up to 100,000 deaths are caused by venous thromboembolism globally.

  • Increase in Number of Cancer Patients - According to the World Health Organization, in 2020, around 2 million new cases of lung cancer and nearly 2.26 million of breast cancer were reported. Moreover, 10 million people died because of cancer.

  • Increased Cases of Injury and Deaths by Road Accidents - Fatal and non-fatal road accidents impose a burden of approximately 8 trillion dollars on the world’s economy and globally every day, around 3700 people die in a road accident.

  • Higher Instances of Renal Failure- For instance, globally, around 850 million people have acquired some kind of kidney problem.

Challenges

  • Side Effects of Heparin in Some Patients - Side effects associated with heparin such as, chest pain, irregular heartbeats, skin discoloration, irregular bleeding, shortness of breath, and others are likely to hamper the growth of the heparin market.

  • The dearth of Raw Material Required for the Heparin Formulation

  • Higher Cost of Certain Types of Heparin

Heparin Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

4.2%

Base Year Market Size (2025)

USD 8.99 billion

Forecast Year Market Size (2035)

USD 13.57 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Heparin Market Segmentation:

Application Segment Analysis

The heart attacks segment is poised to garner highest heparin market share by the end of 2035. This can be attributed to rising prevalence of heart-related disorders across the globe. According to the World Health Organization, in 2019, around 18 million people die due to cardiovascular diseases and the rise in cardiovascular problems is driving the growth of the segment.

Route of Administration Segment Analysis

The subcutaneous injection segment is set to dominate largest market share, owing to growing demand for home healthcare services, low hospitalized associated costs, and a few more properties like convenience in administration. The higher tolerance rate of patients for subcutaneous heparin performs as a benefit for the segment expansion.

Our in-depth analysis of the global market includes the following segments:

         By Product Type

  • Low Molecular Weight Heparin
  • Unfractionated Heparin

         By Route of Administration
  • Intravenous Infusion
  • Subcutaneous Injection

        By Application
  • Deep Vein thrombosis
  • Heart Attack
  • Stroke
  • Atrial Fibrillation
  • Others

          By End-User
  • Hospitals
  • Clinics
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Heparin Market Regional Analysis:

North American Market Insights

North America region is set to dominate around 39.4% market share by 2035. The market growth is attributed to higher number of people developing chronic kidney diseases, followed by surging healthcare expenditure. According to the Centers for Disease Control and Prevention, in 2021, 15% of adults in the United States have chronic kidney disease which is nearly 37 million people in the country. Moreover, rising instances of road accidents will propel the market growth. As of January 2022, about 1 million road accidents took place in the United States.

APAC Market Insights

The heparin market in Asia Pacific is estimated to witness significant growth during the forecast period. The expansion in venous thromboembolism and cardiovascular diseases, increasing geriatric population, rising chronic disease in a large population, growing healthcare expenditure, and initiatives undertaken by the government of the region are the primary factors driving the growth of the market.

Heparin Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Heparin Market Players:

    • Aspen Holdings
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Opocrin S.p.A.
    • LEO Pharma Inc.
    • Baxter
    • Dr. Reddy’s Laboratories Ltd.
    • Pfizer Inc.
    • B. Braun Medical Inc.
    • Bioiberica S.A.U.
    • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
    • Fresenius Kabi Canada

Recent Developments

  • Amcor Group GmbH has launched its latest OmniPack PET bottles to meet the requirements for e-commerce-ready packaging. Amcor has designed a family of stock PET bottles that help co-packers to meet demanding requirements for e-commerce-ready packaging.

  • ALPLA Group along with Voslaur has entered into a partnership to develop a new PET bottle for the Austrian market that will reduce the carbon footprint by 30% and reduces bottle weight by almost 90% in comparison to reusable substitute made up of glass.

  • Report ID: 3402
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of heparin is assessed at USD 9.33 billion.

The global heparin market size was valued at around USD 8.99 billion in 2025 and is projected to grow at a CAGR of more than 4.2%, reaching USD 13.57 billion revenue by 2035.

North America’s heparin market will dominate over 39.4% share by 2035, driven by a higher number of people developing chronic kidney diseases and increasing healthcare expenditure.

Key players in the market include Aspen Holdings, Opocrin S.p.A., LEO Pharma Inc., Baxter, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., B. Braun Medical Inc., Bioiberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada.

Heparin Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos